






Inhibition of angiogenesis as a mechanism for inhibitory effect of 1α-hydroxyvitamin D3 on 
N-methyl-N`-nitro-N-nitrosoguanidine-induced gastrointestinal carcinogenesis in Wistar rats
Akihiko KAWAURA＊，Noritoshi TANIDA＊＊，Keisuke IZUMI＊＊＊，Junichi AKIYAMA＊，





ラットに 0.01％MNNGを 24週間飲水投与した。その後さらに 24週間、第１群は無処置、第２群は




のみの対照群（第１群）は 30匹中 16匹（53％）、MNNG＋MCT群（第２群）は 30匹中 16匹（53％）、
MNNG＋1α（OH）D3 （第３群）は 30匹中８匹（27％）であった。第３群の腫瘍発生率とラット１匹あた
りの腫瘍の個数は第１群のそれに比べ有意に低下している。第１群の vessel count は 3.77で、第 3群の
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した Lews lung carcinoma cell（LLC-GFP cell）を使っ
た in vitroの実験で、血管内皮細胞を活性化し血管




































































































The effect of 1α-hydroxyvitamin D3（1α（OH）D3）on 
the incidence of gastrointestinal tumors induced by 
N-methyl-N`-nitro-N-nitrosoguanidine（MNNG）and 
angiogenesis of gastrointestinal tumors were investigated 
in male Wistar rats. After oral treatment with 0.01% 
MNNG for 24 weeks in rats, 0.04μg of 1α（OH）D3 or 
its vehicle were administered by gastric intubation three 
times a week for 24 weeks. Prolonged administration of 
1α（OH）D3 at a non-hypercalcemic dose significantly 
reduced the incidence of gastrointestinal tumors in week 
48. Administration of  1α（OH）D3 significantly decreased 
the intensity of immunohistochemical staining for 
vascular endothelial growth factor（VEGF）and vessel 
counts in gastrointestinal tumors. These results indicated 
that a non-hypercalcemic dose of  1α（OH）D3 had a 
inhibitory effect on MNNG-induced gasrtointestinal 
carcinogenesis. A possible mechanism of inhibition 
of gastrointestinal carcinogenesis by 1α（OH）D3 is 
mediated by the inhibition of angiogenesis as well as an 
antiproliferative effects.
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